Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals Limited has submitted a certificate to the stock exchange as required under SEBI (Depositories and Participants) Regulations, 2018. This typically relates to compliance with dematerialization of shares, reconciliation of share capital, or related depository requirements. The filing is a routine regulatory disclosure with no specific financial or operational details mentioned in the headline. The exact nature of the certificate (such as a compliance certificate, dematerialization confirmation, or RTA certificate) is not specified.
This is a routine regulatory filing with no material impact on shareholders or stock price. It reflects the company's ongoing compliance with SEBI's depository regulations.